本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Quoin Pharmaceuticals

6.10
-0.5050-7.65%
盤後6.100.00000.00%19:29 EDT
成交量:3.19萬
成交額:20.23萬
市值:358.78萬
市盈率:-0.09
高:7.09
開:6.67
低:6.00
收:6.61
資料載入中...
2023/02/09

SEC問詢函

CORRESP [Cover] - Correspondence
2023/02/09

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2023/02/08

SEC問詢函

CORRESP [Cover] - Correspondence
2023/02/03

招股説明書

S-1 - General form for registration of securities under the Securities Act of 1933
2022/08/12

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/08/04

SEC問詢函

CORRESP [Cover] - Correspondence
2022/08/04

SEC問詢函

CORRESP [Cover] - Correspondence
2022/08/04

[修訂]招股説明書

F-1/A [Amend] - Registration statement for certain foreign private issuers
2022/08/03

招股説明書

F-1 - Registration statement for certain foreign private issuers
2022/04/22

SEC問詢函

CORRESP [Cover] - Correspondence
2022/04/15

招股説明書

F-1 - Registration statement for certain foreign private issuers
2022/04/14

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/11/12

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/08/10

SEC問詢函

CORRESP [Cover] - Correspondence
2021/08/05

SEC問詢函

CORRESP [Cover] - Correspondence
2021/08/03

交易所摘牌聲明

25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
2021/07/16

SEC問詢函

CORRESP [Cover] - Correspondence
2021/03/29

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2021/02/16

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals